Section 71 Request

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1663 (Rev 11/2012)

OMB No. 0651-0055 (Exp 12/31/2018)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1663 (Rev 11/2012)

OMB No. 0651-0055 (Exp 12/31/2018)

Declaration of Continued Use/Excusable Nonuse of Mark in Commerce Under Section 71

To the Commissioner for Trademarks:

REGISTRATION NUMBER: 3936764
REGISTRATION DATE: 03/29/2011

MARK: CELLTRION

The owner/holder, CELLTRION, INC., Limited company legally organized under the laws of Korea, South, having an address of
      23, Academy-ro, Yeonsu-gu,
      Incheon 406-840,,
      Korea, South
is filing a Declaration of Continued Use/Excusable Nonuse of Mark in Commerce Under Section 71.

For International Class 005, this filing does NOT cover the following goods or services for this specific class listed in the registered extension of protection, and these goods or services are to be permanently deleted (removed) from the registration:  Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention of disorders of the immune system; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the prevention of infectious diseases, tumor-related diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations

The mark is in use in commerce on or in connection with the following goods/services, or to indicate membership in the collective membership organization, listed in the existing registered extension of protection for this specific class; or, the owner is making the listed excusable nonuse claim: agents for immunity adjustment, namely, pharmaceutical preparations for the treatment of disorders of the immune system; biological preparations for medical purposes; biopharmaceuticals for the treatment of auto-immune diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) pages from the Physician Prescribing Information used in connection with the goods.

Original PDF file:
SPN0-7513022018-20170324094808700215_._Cl_5_AOU_Specimen.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2

For International Class 035, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registered extension of protection for this specific class; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) screen shot of applicant's webpage showing use of the mark in connection with the services.
Specimen File1

For International Class 040, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registered extension of protection for this specific class; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) a screen shot of applicant's webpage showing use of the mark in connection with the services and a further screen shot of applicant's webpage showing use of the mark in connection with the services that includes the term CMO which stands for "contract manufacturing services".
Specimen File1
Specimen File2

For International Class 042, this filing does NOT cover the following goods or services for this specific class listed in the registered extension of protection, and these goods or services are to be permanently deleted (removed) from the registration:  bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others

The mark is in use in commerce on or in connection with the following goods/services, or to indicate membership in the collective membership organization, listed in the existing registered extension of protection for this specific class; or, the owner is making the listed excusable nonuse claim: Pharmaceutical research and development; biopharmaceutical research and development

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) screen shot of applicant's webpage showing use of the mark in connection with the services.
Specimen File1

For International Class 044, this filing does not cover this specific class. This entire class is to be deleted from the registration. The USPTO will invalidate protection of this class and notify the International Bureau accordingly
The registrant's current Correspondence Information: Dan S. Cohn of  Husch Blackwell LLP
      190 Carondelet Plaza, Suite 600
      St. Louis, Missouri 63122
      United States
The phone number is 314-480-1500.
The fax number is 314-480-1505.
The email address is pto-sl@huschblackwell.com. (not authorized)

The registrant's proposed Correspondence Information: Dan S. Cohn of  Husch Blackwell LLP
      190 Carondelet Plaza, Suite 600
      St. Louis, Missouri 63015
      United States The docket/reference number is 504478.16.

The phone number is 314-480-1500.
The fax number is 314-480-1505.
The email address is pto-sl@huschblackwell.com. (authorized)
The registrant hereby appoints Dan S. Cohn and Alan S. Nemes, Michelle Alvey, Dan S. Cohn, Samuel Digirolamo, S. Myers Dill, Kris Kappel, Tara Allstun of  Husch Blackwell LLP
      190 Carondelet Plaza, Suite 600
      St. Louis, Missouri 63015
      United States
to submit this Declaration of Continued Use/Excusable Nonuse of Mark in Commerce Under Section 71 on behalf of the registrant. The docket/reference number is 504478.16.

The phone number is 314-480-1500.

The fax number is 314-480-1505.

The email address is pto-sl@huschblackwell.com.

The registrant hereby appoints Dan S. Cohn of Husch Blackwell LLP, 190 Carondelet Plaza, Suite 600, St. Louis, Missouri United States 63015 as registrant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The phone number is 314-480-1500.

The fax number is 314-480-1505.

The email address is pto-sl@huschblackwell.com.

A fee payment in the amount of $500 will be submitted with the form, representing payment for 4 class(es), plus any additional grace period fee, if necessary.


Declaration

	Unless the owner/holder has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods/services identified above, as evidenced by the attached specimen(s).
	The specimen(s) shows the mark as currently used in commerce on or in connection with the goods/services.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of this submission, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /Kyungha Shin/    Date: 03/28/2017
Signatory's Name: KYUNGHA SHIN
Signatory's Position: Director

Mailing Address:
   Husch Blackwell LLP
   190 Carondelet Plaza, Suite 600
   St. Louis, Missouri 63015

Serial Number: 79079370
Internet Transmission Date: Tue Mar 28 12:05:15 EDT 2017
TEAS Stamp: USPTO/SECT71-XX.XXX.XXX.XX-2017032812051
5219342-3936764-58029ff2de0241cc4fd5fd46
a98f865cf3fd186d8ca2fb72876b3f52b10653b8
ec3-DA-16070-20170327093319165632